Key statistics
On Wednesday, 10X Genomics Inc (TXG*:MEX) closed at 420.00, 0.00% below its 52-week high of 420.00, set on Aug 28, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 420.00 |
---|---|
High | 420.00 |
Low | 420.00 |
Bid | -- |
Offer | 485.00 |
Previous close | 426.22 |
Average volume | 0.00 |
---|---|
Shares outstanding | 120.49m |
Free float | 103.41m |
P/E (TTM) | -- |
Market cap | 2.73bn USD |
EPS (TTM) | -2.02 USD |
Data delayed at least 20 minutes, as of Aug 28 2024 12:30 BST.
More ▼
Press releases
- Lausanne Researchers Combine 10x Genomics' Chromium and Xenium for Novel Insights into Resistance and Potential Therapeutics for Brain Cancer
- 10x Genomics Unveils Chromium Xo: A Low-Cost Instrument to Expand Access to High-Performance Single Cell Research
- 10x Genomics to Present at the Morgan Stanley 22nd Annual Global Healthcare Conference
- 10x Genomics Announces Senior Leadership Changes
- 10x Genomics Reports Second Quarter 2024 Financial Results
- 10x Genomics Technology Supports TenK10K Project Led by Garvan Institute of Medical Research to Help Transform the Treatment of Complex Diseases
- 10x Genomics to Report Second Quarter 2024 Financial Results on August 8, 2024
- New Insights Into Cleft Palate Unlocked With 10x Genomics' Single Cell and Spatial Technologies
- 10x Genomics Expands Leadership in Single Cell Analysis with Launch of GEM-X Technology
More ▼